Haematologica · 2007 · 33 citations · 8 references
MedicineImmunologyPathologyCancer ImmunologyCellular ImmunologyImmunopathologyBone Marrow PathologyHematologic PathologyImmunoglobulin FunctionMultiple MyelomaImmunofluorescence AssaysImmunofluorescence FindingsMultiple Myeloma Of BoneMyeloma PathogenesisPlasma Cell Biology
Increases in free light chain (FLC) production are associated with disease progression in multiple myeloma (MM). Using a double immunofluorescence staining method to produce a differential count of plasma cells in bone marrow, single populations were demonstrated, containing intact monoclonal immunoglobulins (M-Igs) in 74% and FLCs only in 8% of cases. However, 18% contained a mixture of both cell populations. Progression from cells making intact M-Ig to cells restricted to FLC only production occurred in individual cases during the course of their disease. The presence of FLC only cells was associated with shortened survival.
8
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Robert A. Kyle, Morie A. Gertz, Thomas E. Witzig et al. · Mayo Clinic Proceedings · 2003 · 2.4K citations
Medicine, Hematology, Oncology +10
Serum test for assessment of patients with Bence Jones myeloma
A.R. Bradwell, Hugh D Carr-Smith, Graham P. Mead et al. · The Lancet · 2003 · 286 citations
Serum free light chains for monitoring multiple myeloma
G Mead, Hugh D Carr-Smith, Mark T. Drayson et al. · British Journal of Haematology · 2004 · 196 citations · Full text
Medicine, Hematology, Immunology +14
Growth Rates and Responses to Treatment in Human Myelomatosis
J R Hobbs · British Journal of Haematology · 1969 · 116 citations
Medicine, Hematology, Oncology +13